Stockreport

Santhera's Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States [Yahoo! Finance]

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com
PDF This follows the first commercial launch of AGAMREE in Germany in January 2024 by Santhera AGAMREE is the first DMD treatment approved across the U.S., EU and UK Pr [Read more]